Margetuximab

{
  "id": "MLC-T-ONC-005135",
  "term": "Margetuximab",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with other drugs to treat adults with HER2-positive breast cancer that has spread to other parts of the body. It is used in patients who have already received at least two anti-HER2 treatments, including at least one for metastatic disease. It is also being studied in the treatment of other types of cancer. Margetuximab binds to a protein called HER2, which is found on some cancer cells. This may help the immune system kill cancer cells. Margetuximab is a type of monoclonal antibody. Also called Margenza.",
  "synonyms": [
    "Margenza"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/margetuximab/"
}